St Georgiev V. Chemotherapy of enterobiasis (oxyuriasis). Expert Opin Pharmacother. 2001 Feb;2(2):267-75.
Kimberlin DW, Brady MT, Jackson MA, et al, eds. Red book: 2015 report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2015.
Despommier DD, Gwadz RW, Hotez PJ, et al. Parasitic diseases. 4th ed. New York, NY: Apple Trees Productions; 2000.
Centers for Disease Control and Prevention. Enterobiasis (Enterobius vermicularis). December 2017 [internet publication].
1. Burkhart CN, Burkhart CG. Assessment of frequency, transmission, and genitourinary complications of enterobiasis (pinworms). Int J Dermatol. 2005 Oct;44(10):837-40.
2. St Georgiev V. Chemotherapy of enterobiasis (oxyuriasis). Expert Opin Pharmacother. 2001 Feb;2(2):267-75.
3. Kimberlin DW, Brady MT, Jackson MA, et al, eds. Red book: 2015 report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2015.
4. Centers for Disease Control and Prevention. Parasites - enterobiasis (also known as pinworm infection): epidemiology & risk factors. January 2013 [internet publication].
5. Despommier DD, Gwadz RW, Hotez PJ, et al. Parasitic diseases. 4th ed. New York, NY: Apple Trees Productions; 2000.
6. Centers for Disease Control and Prevention. Enterobiasis (Enterobius vermicularis). December 2017 [internet publication].
7. Lormans JA, Wesel AJ, Vanparus OF. Mebendazole (R 17635) in enterobiasis: a clinical trial in mental retardates. Chemotherapy. 1975;21(3-4):255-60.
8. Sadun EH, Melvin DM. The probability of detecting infection with Enterobius vermicularis by successive examinations. J Pediatr. 1956 Apr;48(4):438-41.
9. Brugmans JP, Thienpont DC, van Wijngaarden I, et al. Mebendazole in enterobiasis. Radiochemical and pilot clinical study in 1,278 subjects. JAMA. 1971 Jul 19;217(3):313-6.
10. Fierlafijn E, Vanparijs OF. Mebendazole in enterobiasis: a placebo-controlled trial in a paediatric community. Trop Geogr Med. 1973 Sep;25(3):242-4.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台